It was recently discovered that a GlaxoSmithKline pharmaceutical plant located in Ireland, held contaminated drug ingredients that possibly affected supplies of weight-loss drugs shipped to the United States and Puerto Rico.
The supplies have since been recalled; however, according to Reuters, officials believe the plant didn’t act fast enough for proper safety precautions.
This article is for Premium Members only. Please login below to read the rest of this article.
Not a Premium Member yet? Become one today.